Poison Pill Provisions in Corporate Bylaws: Protecting Against Hostile Takeovers
The term “poison pill” refers to a defensive mechanism designed to protect a company against hostile takeovers. These provisions are typically embedded in a company’s articles of association (bylaws). In today’s business environment — where outside investors frequently attempt to acquire companies and replace their management — poison pill provisions serve as a critical safeguard. While poison pills take many forms, they all share a common purpose: preventing a hostile takeover without the consent of the company’s existing shareholders or board of directors.
By Igal Mor, Adv. & Notary
Accuracy in Legal Advice. Excellence in legal support.
In recent years, the phenomenon of larger companies acquiring and taking over smaller ones has accelerated significantly. As a result, companies must develop proactive defensive strategies to protect their independence and their shareholders’ interests. Poison pill provisions are among the most effective tools available for this purpose.
Common Types of Poison Pill Mechanisms
Staggered Board of Directors: One common form of poison pill is the staggered appointment of board members, under which a different group of directors is elected every few years on a rotating basis. As a result, an outside investor who acquires a majority stake cannot immediately replace the entire board of directors. This limitation neutralizes a key objective of any hostile takeover and often serves as a powerful deterrent to prospective acquirers.
Trigger-Based Poison Pills: If Event X Occurs, Y Will Result
Preferred Share Dilution: Another widely used poison pill mechanism involves the automatic issuance of preferred shares to existing controlling shareholders. When an outside investor attempts to purchase shares above a predetermined threshold — one that would give them a controlling majority — the board of directors can authorize the issuance of preferred shares to existing owners at a reduced price. This dramatically dilutes the hostile investor’s potential stake while increasing the ownership percentage of existing shareholders. Notably, this type of poison pill also prevents multiple investors from coordinating a joint takeover, since the mechanism treats them as a single entity rather than separate investors.
Although poison pill mechanisms are common worldwide, their use remains relatively uncommon in Israel. The reason is straightforward: most Israeli public companies already have concentrated controlling shareholders who own more than half of the outstanding shares. Since the likelihood of a hostile takeover is low in such cases, there is generally no need for poison pill protections. However, a different concern arises: how to limit the power of a concentrated controlling shareholder to prevent actions that harm minority investors. Israeli company law addresses this through several statutory provisions that protect the general public and prevent controlling shareholders from engaging in conduct detrimental to other investors’ interests.
In summary, poison pill provisions in a company’s bylaws can serve as a powerful tool for protecting shareholders’ capital and preserving the company’s independence — complementing the legal protections already available under Israeli law. Drafting corporate bylaws that incorporate these defensive mechanisms requires considerable legal expertise and strategic sophistication.
We invite you to consult with our team about the strategies available to protect your business from hostile takeover attempts.
Adv. Mor & Co.’s commercial law department has extensive experience representing entrepreneurs, businesses, and corporations — both in Israel and internationally — across all areas of corporate and commercial law. Contact us with any questions about corporate bylaws and defensive provisions by calling 02-595-3322 or messaging us on WhatsApp at 050-441-1343.